The groundbreaking approach of the medication represents a exciting development in the management of the condition. Unlike existing therapies, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment